Hasan MY - Search Results

1

Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl.

Petroianu GA, Nurulain SM, Hasan MY, Kuča K, Lorke DE. Petroianu GA, et al. Among authors: hasan my. J Appl Toxicol. 2015 May;35(5):493-9. doi: 10.1002/jat.3052. Epub 2014 Sep 3. J Appl Toxicol. 2015. PMID: 25186309

2

In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).

Petroianu G, Arafat K, Kosanovic M, Saleh A, Camasamudram V, Hasan MY. Petroianu G, et al. Among authors: hasan my. J Appl Toxicol. 2003 Nov-Dec;23(6):447-51. doi: 10.1002/jat.936. J Appl Toxicol. 2003. PMID: 14635269

3

Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.

Petroianu GA, Hasan MY, Nurulain SM, Shafiullah M, Sheen R, Nagelkerke N. Petroianu GA, et al. Among authors: hasan my. Basic Clin Pharmacol Toxicol. 2006 Oct;99(4):312-6. doi: 10.1111/j.1742-7843.2006.pto_215.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 17040217 Free article.

4

Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.

Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Kuča K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. J Appl Toxicol. 2011 Aug;31(6):515-23. doi: 10.1002/jat.1589. Epub 2010 Oct 27. J Appl Toxicol. 2011. PMID: 20981864

5

Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.

Petroianu GA, Nurulain SM, Shafiullah M, Hasan MY, Kuča K, Lorke DE. Petroianu GA, et al. Among authors: hasan my. J Appl Toxicol. 2013 Sep;33(9):894-900. doi: 10.1002/jat.2760. Epub 2012 May 19. J Appl Toxicol. 2013. PMID: 22611016

6

Acetylcholinesterase inhibitors as pretreatment before acute exposure to organophosphates: assessment using methyl-paraoxon.

Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Kuča K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1052-60. doi: 10.2174/1871527311211080016. CNS Neurol Disord Drug Targets. 2012. PMID: 23244429

7

Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone.

Lorke DE, Nurulain SM, Hasan MY, Kuča K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. J Appl Toxicol. 2014 Oct;34(10):1096-103. doi: 10.1002/jat.2939. Epub 2013 Oct 18. J Appl Toxicol. 2014. PMID: 24136594

8

Optimal Pre-treatment for Acute Exposure to the Organophosphate Dicrotophos.

Lorke DE, Nurulain SM, Hasan MY, Kuca K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. Curr Pharm Des. 2017;23(23):3432-3439. doi: 10.2174/1381612822666161027154303. Curr Pharm Des. 2017. PMID: 27799040

9

Oximes as pretreatment before acute exposure to paraoxon.

Lorke DE, Nurulain SM, Hasan MY, Kuča K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. J Appl Toxicol. 2019 Nov;39(11):1506-1515. doi: 10.1002/jat.3835. Epub 2019 Jul 2. J Appl Toxicol. 2019. PMID: 31264735

10

Combined Pre- and Posttreatment of Paraoxon Exposure.

Lorke DE, Nurulain SM, Hasan MY, Kuča K, Petroianu GA. Lorke DE, et al. Among authors: hasan my. Molecules. 2020 Mar 27;25(7):1521. doi: 10.3390/molecules25071521. Molecules. 2020. PMID: 32230733 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page